Increasing evidence suggests that TRPV1 plays a key role in the regulation of body weight and lipid metabolism and is therefore considered a potential target for the treatment of obesity (22–26). The gene discussed is TRPV1; the disease is obesity due to melanocortin 4 receptor deficiency.